Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 1997

View Archived Issues

Japanese researchers focus on pyripyropenes

Prenyl-protein transferase inhibitors reported by Merck & Co.

Novel cephalosporins reported by Japanese investigators

Nippon Zoki claims aFGF fragments for CNS indications

New vitamin D derivatives from Duphar

Lilly claims IGF-1 superagonists

New AIDS vaccine candidates reported by Institut Pasteur

Fluoxetine plus dexfenfluramine effective in obese patients

Another new application for botulinum toxin reported in the literature

TxA2 antagonists modulate tumor sensitivity to platinum anticancer drugs

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Lipid effects of two gestodene/ethinylestradiol combinations compared

German investigators present potent dopamine D1 antagonist

Two FDA approvals for Taro

Watson/Royce merger approved

Watson's first NDA product approved

FDA advisory panel to discuss penile implant guidelines

Andrx freed to market Dilacor XR bioequivalent

bFGF enters clinical trials for PVD

Generic antidiabetic agent approved by FDA

New HRT patch approved for launch in U.S.

Yale receives grant from Vion

FDA clears Rogaine generic

Procrit cleared for new indication

Biofield seeks approval for new breast cancer diagnostic system

Cambridge NeuroScience/Gladstone Institute AD collaboration

Cephalon files first NDA submission

First NDA submission for NeoPharm seeks approval for two indications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...